Catalyst Pharmaceutical Partners Announces Completion of Enrollment in CPP-109

Catalyst Pharmaceutical Partners Announces Completion of Enrollment in CPP-109

Filed under: drug addiction help line

Catalyst licensed CPP-109 from Brookhaven National Laboratory for the treatment of cocaine and other addictions, and has been granted "Fast Track" status by the US Food and Drug Administration (FDA) for cocaine addiction. Under the Federal Food, Drug, …
Read more on MarketWatch (press release)

 

Battle over background defines Democratic AG race

Filed under: drug addiction help line

She's also enthusiastic about alternative treatment courts related to mental health and drug addiction, and about measures to prevent crime and protect potential victims. “I've spent the past 15 years working with Montana's law enforcement community, …
Read more on Helena Independent Record

 

Five minutes with Joseph Williams

Filed under: drug addiction help line

Drug abuse and addiction is so prevalent in our area that we do not have sufficient treatment slots for those who seek treatment to stop their drug use. Heroin, Methamphetamine and prescription drug abuse are among the popular substances of abuse …
Read more on The Bridgeton News – NJ.com

 

AddictionRecovery411.com Produces Comprehensive Guide to Drug and Alcohol

Filed under: drug addiction help line

An adult can become addicted to illegal and prescription drugs-as well as alcohol-just as easily as a teen can. When abuse has crossed the line into addiction, finding the right treatment plan and the appropriate treatment center is essential to the …
Read more on SBWire (press release)

 

More drug addiction help line Resources

Catalyst Pharmaceutical Partners Announces Completion Of Enrollment In CPP-109 Phase II(b) Clinical Trial For The …
CORAL GABLES, Fla. — Catalyst Pharmaceutical Partners, Inc. today announced that patient enrollment in its CPP-109 vigabatrin Phase II(b) clinical trial has reached its goal of 200 cocaine dependent subjects. … Read News

Leave a Reply

Your email address will not be published. Required fields are marked *